March 13, 2018 / 11:55 AM / 5 months ago

BRIEF-Aevi Genomic Medicine Reports Q4 Loss Per Share $0.13

March 13 (Reuters) - Aevi Genomic Medicine Inc:

* AEVI GENOMIC MEDICINE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.13

* Q4 EARNINGS PER SHARE VIEW $-0.16 -- THOMSON REUTERS I/B/E/S

* AEVI GENOMIC MEDICINE - HAD CASH AND CASH EQUIVALENTS OF $33.73 MILLION AT DECEMBER 31, 2017​

* ‍EXPECTS CURRENT CASH BALANCE TO FUND OPERATIONS INTO EARLY 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below